NCT05857436

Brief Summary

Aim: Apical periodontitis(AP) caused by root canal infection is the most frequent pathological lesion in the jaws. Bacterial products, host immune cells and biologically active factors called locally produced cytokines(such as IL-1, TNF-α) have been reported to play an important role in the pathogenesis of AP. Metalloproteinases(MMP), is a measurable biomarker that plays an important role in the degradation and regeneration of collagen and is an indicator of collagen. This study aimed to determine the main bacterial species in the microbiota as Gr(+) and Gr(-) and to compare the relationship between MMP-9 and TNF-α with controlled patient groups. Methodology:60 patients with AP and extraction indication were included in the study. 30 systemically and orally healthy volunteers were selected as the control group. After access cavity preparation, an initial microbiologic sample(S1) was taken from the root canal. After atraumatic extraction of the tooth, second microbial sample(S2) was taken from the external root surface. After bacterial DNA extraction, 16S rRNA gene primer was designed for sequence analysis. Bacterial community profiling was made by Sanger sequencing of the PCR products. Besides, blood samples were collected from all of the patients. Enzyme-linked immunosorbent assay was used to measure levels of MMP-9 and TNF-α.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 12, 2023

Completed
Last Updated

May 12, 2023

Status Verified

May 1, 2023

Enrollment Period

1 year

First QC Date

April 26, 2023

Last Update Submit

May 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Laboratory Analysis

    Blood samples were collected from the patients for MMP-9 and TNF-α analysis. The blood samples taken from the patients in a tube with a gel separator were kept at room temperature for 20-30 minutes to coagulate, and then centrifuged at 1800 g for 10 minutes. T

    The study was conducted between March 2022 and February 2023

Secondary Outcomes (2)

  • Bacteriological Sampling from the Root Canal System and Outer Root Surface

    The study was conducted between March 2022 and February 2023

  • ELISA measurement procedure of MMP-9 and TNF-α levels

    The study was conducted between March 2022 and February 2023

Study Arms (2)

apical periodontitis

EXPERIMENTAL

60 patients with AP and extraction indication (due to restorative causes and lesion size) were included in the study

Other: apical periodontitis

control

EXPERIMENTAL

A total of 30 volunteers who were determined to be systemically and orally healthy (not having AP indication), were included in the study as the control group.

Other: apical periodontitis

Interventions

Of these patients, 60 patients with AP and extraction indication (due to restorative causes and lesion size) were included in the study

apical periodontitiscontrol

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • AP and extraction indication (due to restorative causes and lesion size) were included in the study

You may not qualify if:

  • Patients who had any acute or chronic inflammatory disease, known infection status, history of trauma or surgical operation within 6 months that may affect MMP-9 levels, pregnant and/or lactating, malignity, morbid obesity, arthritis, immunologic diseases, cardiovascular diseases or use of vitamins with high biotin were not included in the study. Additionally, patients who used antibiotics or anti-inflammatory drugs within the last 6 months, and patients with periodontal disease were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University, Faculty of Dentistry

Istanbul, Esenler, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Periapical Periodontitis

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Study Officials

  • Seyda Ersahan, Assoc.Prof.

    IstanbulMedipol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 26, 2023

First Posted

May 12, 2023

Study Start

November 15, 2021

Primary Completion

November 15, 2022

Study Completion

February 15, 2023

Last Updated

May 12, 2023

Record last verified: 2023-05

Locations